1、  胸部肿瘤发病机制Pathogenesis of thoracic neoplasms

2、胸心外科生物支架的研究（食管胃吻合支架等） Biological stent for cardiothoracic surgery (esophageal gastric anastomosis stent)

同济大学附属同济医院胸外科行政主任、主任医师、同济大学教授、博士生导师，上海市卫生健康领军人才，中国医疗保健国际交流促进会胸部肿瘤分会委员，上海市医学会胸外科分会委员、上海市医师协会胸外科分会副会长、上海市中西医结合学会胸外科分会委员。

Director and Chief physician of thoracic surgery department of Tongji hospital affiliated to Tongji University , Professor and doctoral supervisor of Tongji University. Outstanding Medical Academic Leader.Committee member of thoracic cancer branch of china international exchange and promotion association for medical and healthcare，Member of branch of thoracic surgery shanghai association of medical association.

1995年毕业于同济大学医学院临床医学专业，2002年获同济大学医学院外科学硕士学位，2008年同济大学-法国Toulouse第三大学中法联合培养外科学博士毕业，获博士学位。自1995年进入同济大学附属同济医院从事胸外科临床工作至今，在胸部疾病（肺癌、食管癌、纵隔肿瘤）的外科治疗，胸腔镜外科方面有较丰富的经验。主持国家自然科学基金课题面上项目3项，上海市科委、卫健委重点等省局级项目7项，现主持课题研究经费达200万以上。

主要研究方向为胸部肿瘤发病机制及胸外科生物支架的研究（食管胃吻合支架等的研究）。以第一作者或通讯作者在国内外核心刊物发表论文30余篇，其中SCI论文28篇，最高影响因子41.444；以第一发明人授权国家发明专利6项，实用新型专利10项，转化2项；获上海市科技进步三等奖、上海市医学科技奖三等奖、优秀发明选拔赛金奖、“星光计划”科技创新奖等奖项11项。

先后被评为同济大学医学院泰禾奖、同济医院心目中的好老师、同济医院优秀研究生导师等荣誉；现为同济大学医学院本科生“临床科研方法实训”课程的牵头人；所指导的学生曾获“上海市优秀毕业生”、“宝钢优秀学术特等奖”等奖项；带教学生先后获得8项国家、市、校级科创奖项。

Prof. ZHOU graduated from Tongji university school of medicine, clinical medicine in 1995, he obtained a master’s degree in surgery from Tongji university school of medicine in 2002, then in 2008 he graduated from Tongji university-Université Toulouse III – Paul Sabatier，obtained a doctorate in surgery. Since 1995, he worked on clinical practice of thoracic surgery in Tongji hospital of Tongji university and be good at surgical treatment of chest disease（lung cancer, esophageal cancer, mediastinal tumor） and thoracoscope surgery. Presiding three general projects supported by National Natural Science Foundation of China and 7 projects at provincial and ministerial level.

Dedicating to Pathogenesis of thoracic neoplasms and biological stent for cardiothoracic surgery (esophageal gastric anastomosis stent).As the first and corresponding author, he has published 25 SCI papers, with the highest impact factor of 41.444, Composing one monograph on chest disease，Receiving 11 authorized invention patents, and receiving 8 provincial and ministerial awards.